The latter result was expected as BRCAPRO takes into account only BRCA1 and BRCA2, which explain about 20% of the excess FRR of breast cancer (Parmigiani et al, 1998; Easton, 1999; Peto et al, 1999). The gene discussed is BRCA2; the disease is breast cancer.